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Abstract
Severe asthma is a major health concern. The allergic (IgE-mediated) form of asthma is well known from a pathogenic
viewpoint. We searched the available literature to identify which allergens are most frequently associated with severe,
refractory or life threatening asthma. According to the results, molds, pet dander, cockroach and ragweed were more
frequently responsible for severe asthma. Thunderstorm asthma, in addition, represents a special association between
allergic sensitization and an external climatic factor. A detailed knowledge of the most harmful allergens is mandatory
for an appropriate diagnostic and preventive approach.
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Background
Bronchial asthma, which prevalence is around 5-10%
worldwide [1, 2], remains a major health problem in all
age groups for patients, their families and the community.
The asthma-related respiratory symptoms cause a limita-
tion of everyday activity with consequent absenteeism/
presenteism. Exacerbations may require extra visits,
emergency room admissions, and hospitalizations. Of
note, fatalities continue to be reported [3]. Indeed, in the
majority of patients, asthma can be adequately treated
with the standard of care therapy [4], and most patients
achieve a satisfactory control of the disease. Nonetheless,
a not negligible subgroup of subjects remains “difficult-to-
treat” or “uncontrolled” despite adequate therapy. “Severe”
or “difficult to treat” or “refractory” asthma is a heteroge-
neous condition that encompasses different phenotypes/
endotypes, such as eosinophilic, obesity-related, neutro-
philic, late onset asthma, and remains a major unmet need
[5, 6]. Severe asthma accounts for only 5–10% of all cases,
but it is responsible for the majority of direct and indirect
costs. Thus, severe asthma poses a significant health care
burden accounting for up to 50% of the asthma budget in
developed and developing Countries.
Several multicenter cohort studies of patients with
severe asthma have been published [7–10]. These studies
shed light upon some of the emerging clinical character-
istics of this challenging group of patients and provide
important insights into the strategic priorities for its
management. Managing patients with severe asthma is
complex, and requires a multidisciplinary approach and
a standardized protocol, in addition to a uniform
definition. Asthma is a rare cause of mortality, contrib-
uting to less than 1% of all deaths in most countries
worldwide. Rates of death rise almost exponentially from
mid-childhood to older ages, so the majority of asthma
deaths occur after middle age [11]. Although asthma
mortality trends declined in many high-income
countries, studies have suggested that avoidable factors
still play a major role in preventing severe asthma or
asthma deaths. There is increasing evidence that severe
asthma phenotypes are related to genetic factors, age of
onset, disease duration, exacerbations, rhinosinusal
disease and inflammatory characteristics [12–15]. For in-
stance, in a study in a general population, as part of the
European Community Respiratory Health Survey
(ECRHS), there was no gender difference in asthma
severity in the two surveys. However, those studies sug-
gested that asthma severity might be less stable in
women than in men [16]. Occupational exposures have
also been associated with late-onset, and more severe
asthma [17].
The evidence for a favorable clinical response to
environmental control in severe asthma remains so far
inconsistent. Atopy and allergy have long been
* Correspondence: carlo.lombardi@poliambulanza.it
1Departmental Unit of Allergology- Clinical Immunology, and Respiratory
Diseases, Fondazione Poliambulanza, Via Bissolati, 57, Brescia, Italy
Full list of author information is available at the end of the article
© The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Lombardi et al. World Allergy Organization Journal  (2017) 10:2 
DOI 10.1186/s40413-016-0138-8
associated with asthma and, to some degree, with severe
asthma. (Table 1) [7–10]. It is known that early-life ex-
posures and sensitization to various allergens, occur in
children with severe asthma [18], and the association be-
tween allergy and asthma severity is stronger in children
[19, 20]. In general, the association among specific IgE
sensitization (skin prick test or serum IgE assay), expos-
ure and symptoms usually help to identify the factors
contributing to the severity of disease [21]. Some specific
allergens, in particular cockroach [22] and Alternaria
[23] have been associated with more severe forms of
asthma, and asthma deaths have been associated with
high fungal spore counts in the environment [24]. In
parallel, sensitization to mold has been associated with
increased asthma severity and intensive care admissions
in adults [25]. Another relevant aspect of severe asthma
with allergic sensitization is the relationship with thun-
derstorms (“thunderstorm asthma”). An increasing body
of evidence confirmed the occurrence of asthma epi-
demics during thunderstorms in pollen seasons, in vari-
ous geographical areas [26]. Patients without asthma
symptoms, but affected by seasonal rhinitis can also experi-
ence severe asthma attacks, and there is a link between
thunderstorm asthma and pollen sensitizations [27, 28].
Identifying the possibly related causal allergens is
mandatory for an appropriate therapeutic strategy [29, 30],
although the evidence supporting secondary prevention of
asthma (allergen avoidance) is still weak [31, 32].
To assess the impact of allergenic sensitization on se-
vere asthma, a search of current scientific literature was
performed and the results were filtered to identify
relevant articles or studies with data from well-de-
signed clinical studies in human patients. A PubMed
literature search was performed using the Boolean string
severe asthma* [title/abstract] AND allergic sensitization
[title/abstract] AND atopy [ title/abstract].
Mold sensitization and severe asthma
Allergy is one of the major pathophysiological aspects of
asthma requiring hospitalisation, and the concentration
of IgE antibodies is relevant in severe allergic asthma, as
happens for instance in exacerbations due to rhinovirus
infections [33]. In principle, any allergen can cause se-
vere asthma in sensitized patients. Among children ad-
mitted to hospital for acute exacerbations, more than
85% are allergic. Of note, allergen-carrying particles with
a diameter ≤ 5 microns such as HDM, dog, cat dander
and fungal spores (Aspergillus, Penicillium, Alternaria)
can entry the lower airways, thus more likely to cause
asthma. In this context, it is important to distinguish be-
tween sensitization to thermotolerant fungi which can
colonise the airways (mainly Aspergillus, Penicillium and
Candida) so providing a persistent allergenic stimulus in
the absence of airborne exposure and non-
thermotolerant allergens such as Cladosporium and
Alternaria where allergenic effects are directly related to
airborne content of the spores. The former are associ-
ated with lung damage, whereas the latter are more
closely associated with epidemic thunderstorm episodes.
Several studies have found that there is a correlation be-
tween the severity of allergic diseases and the proteolytic
activity of Alternaria extracts [34]. Furthermore, a pos-
sible key role of sensitization to Alternaria species has
been observed in thunderstorm related severe asthma
[35, 36]. In the specific case Alternaria, the prerequisites
for severe asthma epidemics associated with thunder-
storms are: sensitization, current asthma, sudden large
allergen exposure, thunderstorm with cold outflow oc-
curring at a time and location during an allergen season,
in which many asthmatics are outdoors, sudden release
of large amounts of respirable allergenic fragments, par-
ticularly fungal spores such as Alternaria [35–38]. Mold
sensitivity is usually associated with increased severity of
Table 1 Demography and atopic status data from three of most representative studies on severe asthma
Enfumosa study Tenor study SARP Study
Study design/location Cross-sectional European multicentre
study (9 Countries)
U.S. Multicentre
Observational study
Observational cross-sectional
multicentre study
(9 sites in U.S. and 1 site in U.K.)
Patients (N.) with severe asthma 163 2282 (48% OF TOTAL) 204
Age characteristics Age range: 17-65 yrs Mean age ± SD : 38.9 ± 20.92 yrs Mean age ± SD: 41 ± 13 yrs
Sex Sex ratio (F/M) : 4.4 / 1 Not reportedc Females: 64%
≥1 Positive skin prick test 58%
(VS. 78% OF Controlled asthmatics)
- 71%
(VS. 85% of mild and 87% of
moderate asthma)
Mean total serum IgE 109 KU/L-1, 95% CI: 85-139 106.6 IU/mla 2.0 ± 7.6b
References 2 3 4
aOverall, the TENOR study patients with severe asthma had elevated geometric mean IgE values compared with patients with moderate and mild asthma. IgE
values for children and adolescents increased with asthma severity
bTotal serum IgE (log)
cOverall patients (mild/moderate/severe asthma): females : 2945 (62.2%); males : 1792 (37.8%)
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asthma and hospital admission in adults, while in chil-
dren is related to increased bronchial hyperactivity [39].
Asthma-related deaths are more frequent in young
adults during spore peaking [26, 40]. Molds are an
important causative agent of severe asthma as thus the
term SAFS (Severe Asthma associated with Fugal
Sensitization) has been coined to identify those patients
with severe asthma, not-responsive to standard therapy
[41]. The exact prevalence of mold sensitivity is not well
defined, but it is believed to range between 13% and 78%
in atopic patients [42, 43]. Several species of fungi are
considered responsible for allergic sensitization, but the
more relevant belong to the Ascomycetes family:
Alternaria, Aspergillus, Botrytis, Epicoccum, Fusarium
and Penicillium species [41]. Sensitization to Alternaria
and Cladosporium species are more frequently
associated with persistent and severe asthma [41].
Molds are both outdoor and indoor persistent
allergens, although with seasonal variations, that depend
on climatic factors (rain, humidity, temperature, air
pollutants and wind). Indoor spores can derive from
molds present outdoor, or from inside damp and moist
walls in buildings. Rain is usually necessary for spores
discharge in air, not also from outdoor, but even from
house surfaces, especially during thunderstorms [44].
Each species of fungi presents several allergens, that can
be structural components of the cell and/or derived
from metabolic products [45]. Currently 30 allergens
from Aspergillus sp, 16 from Penicillium sp, 10 from
Cladosporium sp and 9 from Alternaria sp have been
identified. Although there is some documented cross-
reactivity among allergens [46, 47], also species-specific
allergens, such as Asp 1 and Alt 1, have been character-
ized [46, 47]. Exposure to fungal allergens can cause
severe asthma trough 3 different mechanisms: a) inhal-
ation of spores or hyphae, that act as allergens in
patients sensitized; b) fungal colonization of airway, i.e.
allergic bronchopulmonary aspergillosis (ABPA), associ-
ated to sensitization to fungal antigens; c) fungal
colonization of districts different from respiratory tract
(generally skin) in patients sensitized to involved fungi
[33]. This wide spectrum of clinical entities in patients
with sensitization to fungi is due to their potent antige-
nicity and immunomodulatory activities [48]. Immuno-
pathogenesis is mediated by β-glucans and theirs
receptor, dectin-1. In fact, after the recognition of β-glu-
cans, dectin 1 on macrophages surface triggers the re-
lease and the production of several inflammatory
mediators [49]. Recent finding suggest that the immune
response to fungi directs T cell towards Th17 cells,
through dendritic cells action. In the same studies the
Authors demonstrated that induction of Th17 cells
strictly correlates with severe allergic asthma, with pos-
sible steroid resistance [46]. Fungal proteases act as
allergens, and also as mediators of tissue injury, inducing
production of IL-6 and IL-8, proinflammatory citokines
involved in exacerbations of asthma. Moreover, it has
been demonstrated that the receptor activated by prote-
ase (PAR) type 2 is overexpressed in bronchial tissue
from asthmatic patients, suggesting a potential increased
vulnerability to fungi in these subjects [42]. In case of
colonization of the airways a Th-2 hypersensitivity
mechanism is involved. Disease is characterized by
increased severity of asthma, increased IgE serum level,
transient infiltrates in lungs, presence of IgG and IgE
against molds [33, 42]. The most common fungi implicated
in pulmonary colonization are from Aspergillum species,
less frequently Candida, Curvularia and Penicillium
species can be involved [50]. Asthma therapy in this case is
associated with antifungal systemic treatment [42]. The
third mechanism was firstly proposed in 1930 by Wise
et al., who observed that patients with skin and/or nails
fungal infection presented an increased asthma severity
[51], and a significant correlation with sinusitis, rhinitis
and urticaria associated to fungal colonization of skin.
Supporting evidences to this hypothesis are derived
from several trials in which patients affected by severe
asthma and fungal skin infection had a relevant im-
provement in asthma control after itraconozole and flu-
conazole [52, 53]. Sensitization to Asp f 1 and/or Asp f
3 may be more indicative of allergic asthma. [54]. It
was also observed that pediatric severe asthma with
fungal sensitization was associated with more oral ster-
oid therapy and higher IL-33 levels [55].
Pollen sensitization and severe asthma
The relationship occurring between pollen sensitisation
and asthma severity has been widely studied, and an
abundant literature on this aspect is currently available
[13, 33]. The IgE antibody profile for a broad spectrum
of allergen molecules, exhaled nitric oxide (FEno) and
bronchial responsiveness were assessed in asthma
patients. Asthmatic patients showed more frequently
sensitization to grass, tree, weed pollens, furry animals,
mold, latex and foods of plant origin. Asthma prevalence
was increased in patients with food-pollen-perennial
sensitisation. In this group of patients also FEno and
bronchial responsiveness were increased with respect to
groups of patients with sensitization only to pollen , or
food or perennial [56]. Some evidence suggested that air
pollution may interact with airborne allergens enhancing
the risk of atopic sensitization and exacerbation of
symptoms in sensitized subjects. These phenomena are
supported by current in vitro and animal studies show-
ing that the combined exposure to air pollutants and
allergens may have a synergistic or additive effect on
asthma and allergies [57]. Ragweed pollen sensitization
induces asthma much more frequently than other
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pollens [58]. Concerning Olea sensitization, the association
between the presence of asthma and sensitization to Ole e
7 resulted statistically significant [59]. To date, among
pollens, only grass, Parietaria (Wall Pellitory) and Olea
pollen have been suggested as possible triggers in
thunderstorm-related asthma [60]. A thunderstorm-related
asthma episode was observed in Naples (Italy) on June
2004, when six adults and one child received emergency
treatment. All patients showed allergic respiratory symp-
toms upon exposure to Parietaria pollen but they were not
sensitized to grasses [61]. Losappio et al. observed 20
patients with allergic sensitization to Olea pollen
brought to an emergency department in Barletta,
Italy, for sudden and severe asthmatic symptoms in
May 2010 following a violent thunderstorm [36]. On
the basis of these observations, all subjects affected
by pollen allergy should be alerted to the danger of
being outdoors during a thunderstorm in the pollen
season, as such events may be an important cause of
severe asthma exacerbations.
Animal dander sensitization and severe asthma
Pet allergy is considered one the most important causes
of severe or uncontrolled asthma. A specific IgE
response to more than three animal-derived components
was observed to be more common among uncontrolled
severe asthmatics children compared to those with
controlled asthma [62]. Component Resolved Diagnosis
(CRD) allows the identification of specific allergens
associated with the severity of asthma and the identifica-
tion of cross reactive molecules that are clinically signifi-
cant as well as Can f 6 or Fel d 4. They are lipocalin
allergens and could explain the role in cross reactivity of
dog with cat and horse. The physician can advise on
whether or not to keep a household pet or which species
could be tolerated. This may have a huge impact on the
child’s well-being [63]. CRD allows to evaluate the
pattern of sensitization to pet IgE components and its
association with clinical symptoms and their severity.
Specific IgE to Can f 2 was significantly associated with
asthma diagnosis, Can f 3 with moderate/severe rhinitis
and asthma diagnosis, Can f 5 with persistent and
moderate-severe rhinitis, and Equ c 3 with persistent
rhinitis and severe asthma [64]. Furthermore, the
sensitization to Can f 2 and Equ c 1 was more common
in severe asthma than in children with controlled
asthma [65]. Asthmatic children with cat allergy have
higher Fel d 1-specific IgE levels as compared to those
with rhinitis alone, and this suggests that high IgE levels
to Fel d 1 could be a marker of increased asthma risk
[66]. Fel d 2 is a serum albumin, abundant in saliva and
dander. It is a highly cross-reactive molecule, associated
with cat – pork syndrome but only a small number (10-
20%) of patients sensitised to Fel d 2 report immediate
reactions to beef, whereas sensitization to Fel d 2 is
associated with more severe respiratory symptoms [67].
Cockroach allergens sensitization and severe
asthma
Cockroach allergy is recognized as an important cause
of asthma and cockroach-induced asthma was described
as a more severe disease, associated with perennial
symptoms and high levels of total IgE. Cockroaches
produce several allergens that induce sensitization, and
exposure to high levels of cockroach allergens at home
is a major risk factor for symptoms in sensitized individ-
uals [68]. Recent data suggest that cockroach allergen
may be a most relevant urban allergen exposure and
may be related to asthma severity [69]. Indoor allergen
exposure in inner-city areas has been of particular inter-
est given that patients living in urban areas have
increased asthma severity, decreased asthma control,
and greater health care use [70]. Rosenstreich et al.
found that cockroach allergens are easily detectable in
inner-city homes [22]. Furthermore, this study demon-
strated that asthmatic children sensitized and exposed to
high levels of cockroach allergens had an increased
asthma morbidity. Ahluwalia et al. observed that in an
inner-city community with high exposure to cockroach
allergens, there was a more strongly and consistent
association with poor asthma outcomes [71]. Gelber et al.
and Call et al. showed that cockroach sensitization was
more common in asthmatics compared to non-asthmatics
referred to an emergency room. When sensitization was
associated with direct exposure, a very high association
with asthma occurred. [72, 73]. In a study carried out in
Thailand, the possible changes in disease severity and al-
lergen sensitization of children with asthma in an interim
period of 5 years was evaluated [74]. During the years
2004-2009, asthma severity increased with increasing
sensitization to mite and mite plus cockroach. In another
study conducted in a population of elderly urban patients
with asthma, the presence of cockroach-specific serum
IgE was associated with more severe asthma, as reflected
by an increase in airway obstruction and hyperinflation
[75]. In a Polish study it was observed that the concentra-
tion of Bla g 2 in houses was higher than previously
reported in other European countries, and children with
cockroach hypersensitivity had more often severe asthma
than children with other allergies [76]. Previously identi-
fied allergens from Blatella germanica and Periplaneta
americana (the most important domestic species), include
Bla g 2 (inactive aspartic protease), Bla g 4 (calycin), Bla g
5 (glutathione-S-transferase), Bla g 6 (troponin), the
Group 1 cross-reactive allergens Bla g 1 and Per a 1, Per a
3 (arylphorin), and Per a 7 (tropomyosin). On the basis of
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this finding, we suggested that community-based asthma
intervention strategies should prioritize reducing cock-
roach allergen exposure.
Sensitization to food allergens and severe asthma
Workers handling food products and derivatives are at
increased risk of developing occupational asthma.
Exposure to food allergens occurs primarily through
inhalation of dust, steam, vapors and aerosolized
proteins generated during the processing of foods. Most
of the inhaled food allergies are IgE mediated, but
objective evidence of asthma by monitoring peak expira-
tory flows during and off work or specific inhalation
challenges usually provide a reliable diagnostic value
[77]. Wheat may induce the well known baker’s asthma:
albumins and globulins ( LTP, Tri a 14, alfa amylase
inhibitor) are more involved than gluten (low – molecular
– weight - glutenins, alfa, gamma omega 5 gliadin) [78].
Heat proteolytic resistant food allergens such as seafood
(fish and shellfish), plants (LTP), spices, milk (casein), eggs
(lysozyme, ovomucoid) and mushrooms can cause severe
asthma attacks through inhalation [78, 79].
Conclusions
Severe asthma remains a major health concern, due to
its relevant social costs. Despite these critical aspects,
there are still many unmeet needs with regard in
particular the interpretation and comparison of the
various studies carried out; for example, the different
definitions of "severe asthma" adopted in the most
important studies published so far (ENFUMOSA , SARP,
TENOR, etc.) [3–8]. Different clinical and biological
phenotypes of asthma are currently identified. Allergic
asthma, with the atopic sensitization and the TH2 driven
inflammation is the most frequent and the better known
form of asthma [80]. Among the allergens that may
cause asthma, some results to be more frequently associ-
ated to severe forms: molds, cockroach, pet dander, inhaled
food-derived allergens. Also, “thunderstorm asthma” is fre-
quently associated with severe symptoms due to a massive
and sudden exposure to inhalant allergens. Thus, a detailed
knowledge about the relevant allergens and causative
factors is essential to properly diagnose, prevent, and treat
the most severe forms of asthma.
There is evidence from some randomized controlled
studies that ABPA treatment with systemic antifungal
therapy can offer a therapeutic benefit to about 60% of
patients [81].
Allergen immunotherapy (AIT) represents a valuable
therapeutic option. A study of sublingual immunother-
apy to Dermatophagoides in patients with allergic
rhinitis with or without mild intermittent asthma showed
an improved bronchial threshold to allergen challenge
[29]. Another recent double-blind, randomized, placebo-
controlled trial, conducted in 109 European trial sites and
including 834 adults with HDM allergy–related asthma
not well controlled by ICS or combination products, and
with HDM allergy–related rhinitis, demonstrated that the
addition of HDM SLIT tablets increased the time to first
exacerbation during ICS reduction, with an estimated
absolute reduction at 6 months of 9 to 10 percentage
points; the reduction was primarily due to an effect on
moderate exacerbations [30]. Further studies of these ap-
proaches are required in severe asthma. An alternative
and clinically proven approach for atopic severe asthma is
the use of the monoclonal antibody to IgE (omalizumab),
which reduces circulating IgE and leads to down-
regulation of its high affinity receptor FcεR1 on mast cells
and basophils [31]. Different promising therapeutic
options are also currently in development and undergoing
clinical trials for the treatment of severe asthma, including
anti-interleukin agents (mepolizumab, benralizumab,
reslizumab, dupilumab, brodalumab, lebrikizumab) [32].
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